Case study

29 Jun 2021

TFS & a Global Biotech Company


As clinical trials grow increasingly complex, timelines shorten, and R&D costs soar. Today’s
biopharmaceutical companies are under intense pressure. They need to not only improve efficiency
while managing costs, but also be able to flex up or down based on corporate priorities. A global
biotech company partnered with TFS in a Functional Service Provider (FSP) program that provides
a tailored solution to share complementary expertise for the long-term, while ensuring flexibility in
the short-term. Now, eleven years later, the partnership continues to thrive with a new contract signed
through 2022. Here’s how TFS made it happen.


    After many years of working on an ad-hoc basis with TFS and other biopharmaceutical services
    providers, this biotech client decided to move to an FSP model that would allow a deeper partnership
    and more continuity of work. With an established relationship underpinned by a personal, tailored
    approach, TFS was a natural choice for their FSP partner. But building the model would not be easy.
    The client needed to fully erect the model in a tight window to ensure continuity of its programs. That
    meant rapid, intensive training for the TFS CRAs, CTAs, line managers and trainers deployed across its
    clinical trials. Given the diversity of the trials which spanned multiple therapeutic areas; hematology,
    cardiovascular, oncology, inflammatory diseases amongst others, the team needed to have both
    breadth and depth of knowledge to succeed.

    See Other Case Studies

    TFS involved in European global customer’s pre-lau...

    TFS was requested to prepare and conduct a Late Phase global proposal to support the pre-launch activities of two pro...

    Read more

    How TFS Strategic Resourcing Solutions deployed a ...

    Given the catastrophic spread of COVID-19, the search for safe and effective therapies has taken on an unpreced...

    Read more

    Rescue of 'At-Risk' Trial H5N1 Vaccine Study / Hea...

    The complexities of coordinated enrollment to meet or exceed timelines are inherent with vaccine trials. Equally esse...

    Read more